Corrigendum to: “Re: Surgical Morbidity Associated with Administration of Targeted Molecular Therapies before Cytoreductive Nephrectomy or Resection of Locally Recurrent Renal Cell Carcinoma” [Eur Urol 2009;55:990–1]
2009 ◽
Vol 27
(1)
◽
pp. 108-109
◽
2008 ◽
Vol 180
(1)
◽
pp. 94-98
◽
2010 ◽
Vol 28
(3)
◽
pp. 241-242
◽
Keyword(s):